Tigermed updates governance policies, reduces registered capital

Hangzhou Tigermed Consulting’s board of directors approved several key governance updates. These include revisions to the company's "Management system for company shares held by directors and senior management, and their changes," "Management system for foreign exchange derivative transactions," "Information disclosure management system," and "Management system for funds raised from equity offerings."

Additionally, a new "Internal audit system" and "Report responsibility system for major errors in annual information disclosure" were enacted, while the "Investment decision-making management system" was abolished.

The company also confirmed the reduction of its registered capital from 864,948,570 yuan to 861,026,050 yuan following the cancellation of 3,922,520 repurchased shares. These changes, alongside updated rules for external investments and related-party transactions, aim to enhance risk control, improve operational efficiency, and protect investor interests. All updates will be submitted for shareholder approval.